Key result
Adiponectin may protect against diabetic retinopathy by reducing insulin resistance, oxidative stress, and inflammation.
Why the study?
A growing body of research indicates adiponectin plays a significant role in diabetic retinopathy, prompting exploration of its protective effects and potential therapeutic targets.
Adiponectin is a potential therapeutic target and predictive marker for diabetic retinopathy due to its anti-inflammatory, anti-oxidative, and vascular protective effects.
No takes yet. Share an insight, caveat, or question.
Adiponectin merits study as biomarker and target in diabetic retinopathy; leaves open any practice change pending prospective trials.
Deng et al. (2023) conducted a review in Diabetic Retinopathy. Adiponectin was evaluated. Adiponectin may have a protective effect on the development and progression of diabetic retinopathy by improving insulin resistance, alleviating oxidative stress, and limiting inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: